ArticleBioengineering (Basel, Switzerland)2024
Depth-Aware Networks for Multi-Organ Lesion Detection in Chest CT Scans.
Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computer tomography (CT) scans' capabilities in detecting lesions have been increasing remarkably in the past decades. In this paper, we propose a multi-organ lesion detection (MOLD) approach to better address real-life chest-related clinical needs. MOLD is a challenging task, especially within a large, high resolution image volume, due to various types of background information interference and large differences in lesion sizes. Furthermore, the appearance similarity between lesions and other normal tissues demands more discriminative features. In order to overcome these challenges, we introduce depth-aware (DA) and skipped-layer hierarchical training (SHT) mechanisms with the novel Dense 3D context enhanced (Dense 3DCE) lesion detection model. The novel Dense 3DCE framework considers the shallow, medium, and deep-level features together comprehensively. In addition, equipped with our SHT scheme, the backpropagation process can now be supervised under precise control, while the DA scheme can effectively incorporate depth domain knowledge into the scheme. Extensive experiments have been carried out on a publicly available, widely used DeepLesion dataset, and the results prove the effectiveness of our DA-SHT Dense 3DCE network in the MOLD task.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.